What raises the risk of NSAID-related stomach bleeding

A patient may use an NSAID for pain while also taking medicines that affect clotting or irritate the stomach. That combination deserves attention because NSAID-related ulceration and gastrointestinal bleeding can occur without warning symptoms and may be serious.

FDA-listed factors that raise risk

• Use of anticoagulants or corticosteroids.
• Longer duration of NSAID use.
• Smoking or drinking alcohol.
• Older age or poor general health.
• History or symptoms that may suggest ulcer or gastrointestinal bleeding, which require pharmacist or prescriber review.

Why combination therapy matters

An anticoagulant can increase bleeding consequences, while corticosteroids are listed in NSAID medication guides among medicines that raise ulcer or bleeding risk. The full medication list, dose, duration and patient history matter. Do not assume an over-the-counter NSAID is harmless because it is available without a prescription.

Technician response

When processing an order or answering a question, notice duplicate NSAIDs and potentially concerning combinations, then follow the pharmacy's DUR and escalation process. If a patient reports black stools, vomiting blood, severe abdominal symptoms or unusual bleeding, promptly alert the pharmacist and follow urgent-care procedures. Do not advise the patient to start, stop or substitute therapy on your own.

Exam takeaway

NSAID GI bleeding risk rises with anticoagulants, corticosteroids, longer use, smoking, alcohol, older age and poor health. The pharmacy technician recognizes the risk and refers it to the pharmacist.

Understand the medication class and the type of risk

Nonsteroidal anti-inflammatory drugs (NSAIDs) include prescription and over-the-counter products such as ibuprofen, naproxen, and many other agents. NSAIDs can cause stomach or intestinal ulcers and bleeding, sometimes without warning symptoms. The risk is not limited to a person taking a high prescription dose; duration, medical history, age, and other medicines also matter. Some patients take more than one NSAID because they do not recognize that an OTC pain reliever belongs to the same class as a prescription product. A complete medication history should include nonprescription products and supplements.

Medication combinations that deserve review

FDA-approved NSAID Medication Guides warn that anticoagulants and corticosteroids can raise the risk of ulceration or bleeding. Other factors listed in labeling include longer duration, smoking, alcohol use, older age, and poor general health; a history of ulcers or bleeding also matters. These factors do not let a technician calculate an individual’s risk or determine a safe combination. They are signals to use the pharmacy’s drug-utilization review process and involve the pharmacist. The specific product labeling can contain additional warnings, so do not treat one short list as exhaustive for every NSAID or patient.

Recognize urgent symptoms

Black or tarry stools, vomiting blood or material that looks like coffee grounds, unusual bleeding, faintness, or severe persistent abdominal symptoms can indicate a serious problem. If a patient reports these symptoms, promptly notify the pharmacist and follow the pharmacy’s urgent response policy. If there is immediate danger, activate emergency services according to protocol. Do not tell the patient to wait for a routine appointment, stop an anticoagulant, or discontinue a prescribed NSAID on your own. The pharmacist or prescriber evaluates the symptoms and gives patient-specific instructions.

Use a medication-history and duplicate-therapy check

When processing an order, review the patient profile and ask about OTC pain, cold, and combination products according to the pharmacy’s intake process. Look for two NSAIDs, duplicate ingredients, an NSAID with an anticoagulant or corticosteroid, and prolonged use that may need professional review. A claim may not reveal nonprescription use, so a targeted question can matter. If the system flags an interaction, do not dismiss it as irrelevant because the NSAID is sold without a prescription. Record the reported products and route the alert through the pharmacist.

Example and exam takeaway

A patient picks up naproxen and mentions taking ibuprofen most evenings while also taking a prescribed anticoagulant. The technician should recognize duplicate NSAID use and a potentially important bleeding-risk combination, then alert the pharmacist. The technician should not recommend a dose change or tell the patient which product to stop. For the PTCE, remember that NSAID-related GI injury can be serious and risk is affected by other medicines and patient factors. Identify the concern, follow DUR and escalation procedures, and treat bleeding symptoms as urgent.

Application notes and common edge cases

A risk factor is a reason for professional review, not a prediction that bleeding will occur. The pharmacist considers the specific NSAID, dose, duration, age, ulcer history, kidney and other health conditions, and the full medication list. Do not reassure someone that a short course or OTC product has no meaningful risk, and do not state that every patient with one risk factor must avoid all NSAIDs.

Combination cold, headache, and menstrual-pain products may contain an NSAID or another ingredient that duplicates a medicine already in the profile. Ask patients to bring or name nonprescription products where appropriate. Read active ingredients rather than relying on package colors or the front-panel brand name. Potential duplication should be routed through the pharmacy’s drug-utilization review process.

FDA-approved medication guides and product labeling may be revised. If a specific product has a more detailed warning than the general class information, use that current labeling and pharmacist guidance. This article supports exam learning and does not replace individualized medical advice or the product’s official instructions.

NSAID-related ulceration and bleeding can occur without warning symptoms, according to FDA-approved medication guidance. Therefore, lack of stomach pain does not prove the combination is safe. If the patient reports black stools, vomiting blood, faintness, or bloody stool, treat the report as urgent and alert the pharmacist immediately. Do not delay escalation while asking detailed routine medication-history questions.

FDA patient information notes that NSAID-related ulcers and bleeding may occur at any time during treatment and without warning symptoms. That is why a technician should escalate risk combinations even when the patient feels well. The pharmacist can discuss the specific product, duration, and safer alternatives with the patient or prescriber.